A Comprehensive Analysis of In Vitro and In Vivo Genetic Fitness of Pseudomonas aeruginosa Using High-Throughput Sequencing of Transposon Libraries

PLoS Pathogens

Volumn 9, Issue 9, 2013, Pages

  Skurnik, David ^a   Roux, Damien ^a   Aschard, Hugues ^b   Cattoir, Vincent ^c   Yoder Himes, Deborah ^c   Lory, Stephen ^c   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; PILIN; PORIN; SECRETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BIOINFORMATICS; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; IMMUNE RESPONSE; IMMUNOTHERAPY; ION TRANSPORT; MICROBIAL RESPIRATION; MOUSE; NEUTROPENIA; NONHUMAN; NUTRIENT UPTAKE; OXIDATION REDUCTION REACTION; POLYMERASE CHAIN REACTION; PROPHAGE; PSEUDOMONAS AERUGINOSA; REPRODUCTIVE FITNESS; TRANSPOSON; UPREGULATION;

ANIMALS; BACTERIAL PROTEINS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; GENE LIBRARY; GENES, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICE; PSEUDOMONAS AERUGINOSA; VIRULENCE FACTORS;

EID: 84884678257     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003582     Document Type: Article

References (54)

1. Mei JM, Nourbakhsh F, Ford CW, Holden DW, (1997) Identification of Staphylococcus aureus virulence genes in a murine model of bacteremia using signature-tagged mutagenesis. Mol Microbiol 26: 399-407.
2. Lehoux DE, Sanschagrin F, Levesque RC, (2002) Identification of in vivo essential genes from Pseudomonas aeruginosa by PCR-based signature-tagged mutagenesis. FEMS Microbiol Lett 210: 73-80.
3. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, et al. (2003) In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5: 1294-1308.
4. Sassetti CM, Boyd DH, Rubin EJ, (2001) Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci U S A 98: 12712-12717.
5. Sassetti CM, Boyd DH, Rubin EJ, (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48: 77-84.
6. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, et al. (2009) Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6: 279-289.
7. van Opijnen T, Camilli A, (2012) A fine scale phenotype-genotype virulence map of a bacterial pathogen. Genome Res 22: 2541-2551.
8. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ, (2009) Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 106: 16422-16427.
9. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7: R90.
10. Mikkelsen H, McMullan R, Filloux A, (2011) The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLoS One 6: e29113.
11. Tancrede CH, Andremont AO, (1985) Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152: 99-103.
12. Walsh TJ, Roilides E, Groll A, Gonzalez C, Pizzo P (2011) Infectious Complications in the Pediatric Cancer Patient; Pizzo P, Poplack D, editors. Philadelphia: Lippincott Williams & Wilkins.
13. Fanci R, Paci C, Anichini P, Pecile P, Marra G, et al. (2003) Incidence and molecular epidemiology of Pseudomonas aeruginosa bacteremias in patients with acute leukemia: analysis by pulsed-field gel electrophoresis. New Microbiol 26: 353-361.
14. Koh AY, Mikkelsen PJ, Smith RS, Coggshall KT, Kamei A, et al. (2010) Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination. PLoS One 5: e15131.
15. Koh AY, Priebe GP, Pier GB, (2005) Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun 73: 2262-2272.
16. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, et al. (2006) An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103: 2833-2838.
17. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 14339-14344.
18. Wong SM, Mekalanos JJ, (2000) Genetic footprinting with mariner-based transposition in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 97: 10191-10196.
19. Serate J, Roberts GP, Berg O, Youn H, (2011) Ligand responses of Vfr, the virulence factor regulator from Pseudomonas aeruginosa. J Bacteriol 193: 4859-4868.
20. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, et al. (2011) Pseudomonas genome database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39: D596-600.
21. Burrows LL, (2012) Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu Rev Microbiol 66: 493-520.
22. Whitchurch CB, Mattick JS, (1994) Characterization of a gene, pilU, required for twitching motility but not phage sensitivity in Pseudomonas aeruginosa. Mol Microbiol 13: 1079-1091.
23. Darzins A, (1995) The Pseudomonas aeruginosa pilK gene encodes a chemotactic methyltransferase (CheR) homologue that is translationally regulated. Mol Microbiol 15: 703-717.
24. Darzins A, (1994) Characterization of a Pseudomonas aeruginosa gene cluster involved in pilus biosynthesis and twitching motility: sequence similarity to the chemotaxis proteins of enterics and the gliding bacterium Myxococcus xanthus. Mol Microbiol 11: 137-153.
25. Bertrand JJ, West JT, Engel JN, (2010) Genetic analysis of the regulation of type IV pilus function by the Chp chemosensory system of Pseudomonas aeruginosa. J Bacteriol 192: 994-1010.
26. Koo J, Tammam S, Ku S-Y, Sampaleanu LM, Burrows LL, et al. (2008) PilF Is an outer membrane lipoprotein required for multimerization and localization of the Pseudomonas aeruginosa type iv pilus secretin. J Bacteriol 190: 6961-6969.
27. de Bentzmann S, Aurouze M, Ball G, Filloux A, (2006) FppA, a novel Pseudomonas aeruginosa prepilin peptidase involved in assembly of type IVb pili. J Bacteriol 188: 4851-4860.
28. Giraud C, de Bentzmann S, (2011) Inside the complex regulation of Pseudomonas aeruginosa chaperone usher systems. Environ Microbiol 14: 1805-1816.
29. Carter MQ, Chen J, Lory S, (2010) The Pseudomonas aeruginosa pathogenicity island PAPI-1 is transferred via a novel type IV pilus. J Bacteriol 192: 3249-3258.
30. Yoneyama H, Nakae T, (1993) Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 37: 2385-2390.
31. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, et al. (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4: 1247-1253.
32. Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, et al. (2006) Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A 103: 12487-12492.
33. Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, et al. (2008) Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol 181: 586-592.
34. Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, et al. (2012) The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog 8: e1002945.
35. Filloux A, Bleves S, van Ulsen P, Tommassen J (2004) Protein secretion mechanisms in pseudomonas. In: Ramos J-L, editor. Pseudomonas. New York: Springer-Verlag. pp. 750-760.
36. Espinosa-Urgel M, Salido A, Ramos JL, (2000) Genetic analysis of functions involved in adhesion of Pseudomonas putida to seeds. J Bacteriol 182: 2363-2369.
37. Hinsa SM, Espinosa-Urgel M, Ramos JL, O'Toole GA, (2003) Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein. Mol Microbiol 49: 905-918.
38. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, et al. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170-177.
39. Ryder C, Byrd M, Wozniak DJ, (2007) Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 10: 644-648.
40. Franklin MJ, Nivens DE, Weadge JT, Howell PL, (2012) Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front Microbiol 2: 167.
41. Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, et al. (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19: 12-23.
42. Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, et al. (2008) Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol 190: 2739-2758.
43. Gallagher LA, Shendure J, Manoil C, (2011) Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq. MBio 2: e00315-00310.
44. Khatiwara A, Jiang T, Sung SS, Dawoud T, Kim JN, et al. (2012) Genome scanning for conditionally essential genes in Salmonella enterica Serotype Typhimurium. Appl Environ Microbiol 78: 3098-3107.
45. Micol JB, de Botton S, Guieze R, Coiteux V, Darre S, et al. (2006) An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteremia in hematology patients. Haematologica 91: 1134-1138.
46. Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, et al. (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med 160: 501-509.
47. Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB, (2011) Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection. Infect Immun 79: 1289-1299.
48. Priebe GP, Meluleni GJ, Coleman FT, Goldberg JB, Pier GB, (2003) Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect Immun 71: 1453-1461.
49. Zaidi TS, Priebe GP, Pier GB, (2006) A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infect Immun 74: 975-983.
50. Goodman AL, Kulasekara B, Rietsch A, Boyd D, Smith RS, et al. (2004) A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 7: 745-754.
51. Miller VL, Mekalanos JJ, (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
52. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, et al. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 1899-1902.
53. Skurnik D, Davis J, Michael R, Benedetti D, Moravec KL, Cywes-Bentley C, et al. (2012) Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis 205: 1709-1718.
54. Hoang TT, Kutchma AJ, Becher A, Schweizer HP, (2000) Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43: 59-72.